Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

Branded and Biosimilar Ophthalmology

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

This public procurement record has 2 releases in its history.

Award

24 Nov 2025 at 00:00

OJEU - F3 - Contract Award Notice
Tender

06 Aug 2025 at 01:00

OJEU - F2 - Contract Notice
Summary of the contracting process

The Common Services Agency, better known as NHS National Services Scotland, is overseeing the procurement process titled "Branded and Biosimilar Ophthalmology." This tender is primarily focused on the healthcare industry, specifically targeting the supply of branded and biosimilar ophthalmology medicines to NHS Scotland. Located in Edinburgh, the procurement follows an open procedure and is currently at the tender stage. Key deadlines include the submission deadline on 5th September 2025, with the award phase beginning the same day. The contract covers deliveries across all entities under the National Health Service (Scotland) Act 1978 and any Integrated Joint Boards established according to Scottish legislation. The procurement is valued at approximately £146,579,216 GBP.

This tender presents significant opportunities for businesses, particularly those in the pharmaceutical industry specialising in ophthalmology products. Companies with expertise in manufacturing and distributing branded and biosimilar medicines can benefit greatly by participating. The framework consists of multiple lots, including single supplier frameworks for specific drugs like Aflibercept and Faricimab, as well as multi-supplier frameworks for others like Aflibercept Biosimilar and Ranibizumab. Businesses capable of adhering to strict quality and regulatory requirements, such as possessing a valid UK Marketing Authorisation and ISO 9001 certification, will have a competitive edge. Moreover, this tender includes community benefit provisions, encouraging suppliers to engage with NHS Scotland’s Community Benefits Gateway to foster local community development.

How relevant is this notice?

Notice Information

Notice Title

Branded and Biosimilar Ophthalmology

Notice Description

Supply of Branded and Biosimilar Ophthalmology to NHS Scotland.

Lot Information

Aflibercept (Eylea(r))

Supply of Aflibercept (Eylea(r)) vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as a single supplier framework to a single Framework Participant.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Aflibercept Biosimilar

Supply of Aflibercept Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to five (5) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Ranibizumab vials and Pre-filled Syringes

Supply of Ranibizumab Branded and Biosimilar vials and Pre-filled Syringes to NHS Scotland. The Authority has awarded this Framework as an unranked multi- supplier framework to two (2) Framework Participants.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Faricimab (Vabysmo(r))

Supply of Faricimab vials and Pre-filled Syringes to NHS Scotland. The Authority has not awarded this Framework to any suppliers.

Renewal: This framework includes the option to extend for any number of periods, up to a maximum overall period of thirty six (36) months upon giving not less than three (3) months written notice, such notice to expire no later than the date the Framework Agreement is due to expire.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-r6ebe6-0000791665
Publication Source
Public Contracts Scotland
Latest Notice
https://www.publiccontractsscotland.gov.uk/search/show/search_view.aspx?ID=NOV544192
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large, SME

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£146,579,216 £100M-£1B
Lots Value
£146,579,217 £100M-£1B
Awards Value
Not specified
Contracts Value
£20,671,084 £10M-£100M

Notice Dates

Publication Date
24 Nov 20259 months ago
Submission Deadline
5 Sep 2025Expired
Future Notice Date
Not specified
Award Date
30 Oct 202510 months ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Complete
Awards Status
Unsuccessful
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
EDINBURGH
Postcode
EH12 9EB
Postcode Area
Edinburgh
Country
Scotland
Major Region (ITL 1)
TLM Scotland
Basic Region (ITL 2)
TLM1 East Central Scotland
Small Region (ITL 3)
TLM13 City of Edinburgh
Delivery Location
TLM Scotland
Local Authority
City of Edinburgh
Electoral Ward
Drum Brae/Gyle
Westminster Constituency
Edinburgh South West

Supplier Information

Number of Suppliers
7
Supplier Names

Bayer Plc

Biogen Idec Ltd

Celltrion Healthcare United Kingdom Limited

MD Biologics

Mercury Pharmaceuticals Limited

Sandoz

Teva UK Ltd

Further Information

Notice Documents

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...